Utah Medical Products, Inc.

Healthcare

NASDAQ:UTMD · NASDAQ Global Select

Market Cap $213.46M Beta 0.37 P/E (TTM) 19.6

$67.04 +1.67%

+$1.10 today

52W Low $52.00High $71.81

Vol 0.02M · Avg 0.01M

EPS (TTM) $3.41 Div Yield 1.85%Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+24.56%

Period High

$70.33

Period Low

$53.00

Latest

$67.04

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Prenetics Global Limited

NASDAQ:PRE

$343.75M

OraSure Technologies, Inc.

NASDAQ:OSUR

$298.46M

Perspective Therapeutics, Inc.

AMEX:CATX

$232.14M

Profound Medical Corp.

NASDAQ:PROF

$205.76M

InfuSystem Holdings, Inc.

AMEX:INFU

$183.45M

KORU Medical Systems, Inc.

NASDAQ:KRMD

$180.75M

Coherus Oncology, Inc.

NASDAQ:CHRS

$173.45M

Protalix BioTherapeutics, Inc.

AMEX:PLX

$169.60M

Neuronetics, Inc.

NASDAQ:STIM

$85.21M

Nyxoah S.A.

NASDAQ:NYXH

$60.36M

What is the latest UTMD filing?

The latest filing shown is 4 dated May 29, 2026.

How many recent filings does UTMD have?

Intrinsic Alpha currently shows 20 recent filings for UTMD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.